Target
Peroxisome proliferator-activated receptor gamma
Ligand
BDBM50193753
Substrate
n/a
Meas. Tech.
ChEMBL_424080 (CHEMBL855083)
IC50
540±n/a nM
Citation
 Hopkins, CRO'neil, SVLaufersweiler, MCWang, YPokross, MMekel, MEvdokimov, AWalter, RKontoyianni, MPetrey, MESabatakos, GRoesgen, JTRichardson, EDemuth, TP Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-gamma binding agents with potential application to the treatment of osteoporosis. Bioorg Med Chem Lett 16:5659-63 (2006) [PubMed]  Article 
Target
Name:
Peroxisome proliferator-activated receptor gamma
Synonyms:
NR1C3 | Nuclear receptor subfamily 1 group C member 3 | PPAR-gamma | PPARG | PPARG_HUMAN | Peroxisome proliferator-activated receptor | Peroxisome proliferator-activated receptor gamma (PPAR gamma) | Peroxisome proliferator-activated receptor gamma (PPARG) | Peroxisome proliferator-activated receptor gamma (PPARĪ³) | Peroxisome proliferator-activated receptor gamma/Nuclear receptor corepressor 2 | peroxisome proliferator-activated receptor gamma isoform 2
Type:
Nuclear Receptor
Mol. Mass.:
57613.46
Organism:
Homo sapiens (Human)
Description:
P37231
Residue:
505
Sequence:
MGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDLSVMEDHSHSFDIKPFTTVDFSSISTPHYEDIPFTRTDPVVADYKYDLKLQEYQSAIKVEPASPPYYSEKTQLYNKPHEEPSNSLMAIECRVCGDKASGFHYGVHACEGCKGFFRRTIRLKLIYDRCDLNCRIHKKSRNKCQYCRFQKCLAVGMSHNAIRFGRMPQAEKEKLLAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY
  
Inhibitor
Name:
BDBM50193753
Synonyms:
1-(3-(trifluoromethyl)benzyl)-5-hydroxy-N-(3-(trifluoromethyl)phenylsulfonyl)-1H-indole-2-carboxamide | CHEMBL374657
Type:
Small organic molecule
Emp. Form.:
C24H16F6N2O4S
Mol. Mass.:
542.45
SMILES:
Oc1ccc2n(Cc3cccc(c3)C(F)(F)F)c(cc2c1)C(=O)NS(=O)(=O)c1cccc(c1)C(F)(F)F
Structure:
Search PDB for entries with ligand similarity: